GSK Venture Capital Arm Goes Independent With $500m Fund

SR One Focused on Establishing Elite US And EU Biotechs

 
• By Kevin Grogan
  
GSK_HQ
SR One was GSK's VC ARM for 35 years • Source: Archive
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business